UK Neurology Devices Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 7.50 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
UK Neurology Devices Market Analysis
The UK neurology devices market is expected to grow with a CAGR of 7.5% during the forecast period. The impact of COVID-19 was adverse on the neurology devices market owing to the cancellations in elective procedures, including neurosurgery which impacted the market.
- For instance, an article published by WHO stated that in the single-center cohort analysis, an overall reduction in neurosurgical operative activity by 65% was observed in 2020 compared to the previous year in the United Kingdom. However, the market started to gain traction as elective procedures resumed. The increasing number of neurological diseases and rising investment in research and development activities to develop innovative neurological devices are projected to boost market growth in the coming years.
- The key factors propelling the growth of the market are the increasing incidence of neurological disorders like brain aneurysms, brain tumors, epilepsy, memory disorders, multiple sclerosis, Parkinson's disease, peripheral neuropathy, spinal cord tumor, and stroke, and the increase in research and development activities in the field of neurotherapy.
- According to Alzheimer's Society report, the projected number of older people with dementia in 2020 was 907,900 in the United Kingdom, 769,200 in England, and 67,900 in Scotland. The report also mentioned the projected number of older people with dementia is likely to reach 1,590,100 in the United Kingdom by 2040. Dementia is caused by Alzheimer's disease, which is a neurological disorder. The high burden of such diseases in the country is likely to propel the demand for neurological devices for the management of such diseases and thereby augment market growth.
- In addition, the increasing healthcare spending, increasing investment by medical device manufacturers, and government funding for research and development activities for neurological disease are expected to drive the overall Neurology Devices market growth in the United Kingdom. For instance, as per the Department of Health and Social Care, the United Kingdom government has planned to invest GBP 375 million in November 2021 over the next five years to improve understanding and treatment for a variety of neurodegenerative diseases. This high spending by the government on neurodegenerative diseases is anticipated to boost the demand for neurology devices used for the diagnosis and management of diseases, which is projected to propel market growth.
- Therefore, owing to the aforementioned factors, the studied market is anticipated to witness growth over the analysis period. However, the high cost of devices and stringent regulatory validation and guidelines for new devices is likely to impede the market growth.
UK Neurology Devices Market Trends
This section covers the major market trends shaping the UK Neurology Devices Market according to our research experts:
Neurostimulation Devices Expected to Witness Significant Growth Over The Forecast Period
- Neurostimulation devices are implantable, programmable medical devices that deliver electrical stimulation to specific parts of the patient's brain, spinal cord, or peripheral nervous system to help treat various conditions, including chronic pain, movement disorders, epilepsy, and Parkinson's disease. Neuromodulation is an intracranial, electrical neuromodulation therapy with Food and Drug Administration approval for treating most neurological conditions such as bladder control, headache, tremors, chronic pain, stroke, minimally conscious state, and spinal cord injury, which are most commonly found in the elderly population.
- The high burden of neurological diseases and the increasing use of neurostimulation to treat such conditions is projected to augment the segment's growth. As per NICE, in 2020, there were around 137,000 people having Parkinson's disease in the United Kingdom. Also, in September 2022, the National Institute for Health and Care Excellence (NICE) issued a recommendation that ReActiv8 Restorative Neurostimulation is used in the National Health Service in the United Kingdom with special arrangements for clinical governance, consent, and audit or research. The high burden of neurological diseases is associated with the increase in the utility of neurostimulation devices for their management and is ultimately projected to boost the market growth.
- Furthermore, the key market players' technological advancement, product launches, and availability of devices in the United Kingdom are propelling the segment's growth. For instance, in November 2021, Neuvana LLC, a wellness and neuroscience technology company, launched its new product, Xen, to be available to consumers in the 27 countries that comprise the European Union and the United Kingdom. Xen is a pocket-sized device that connects to a mobile phone through an app and sends a gentle electrical signal through patented earbuds to stimulate the vagus nerve in the ear. Such technological advancements and launches are linked to boosting the demand for these devices, which is ultimately projected to increase during the forecast period.
Rising Aging Population Expected to Propel the Market Growth Over The Forecast Period.
- The prevalence of most neurological diseases increases with age, and age also modulates the impact of risk factors, clinical presentation, and the natural course of these diseases.
- According to NHS Digital 2022 report, in England in 2022, 689,079.8 patients aged 65 years and above with dementia were estimated to be diagnosed, out of which 424,326 patients were diagnosed. The diagnosis rate was 61% in England. The estimated number of elderly patients with dementia diagnosed with dementia is 71,179.4 in London. The high burden of dementia in the United Kingdom is expected to propel market growth.
- Furthermore, according to the Office for National Statistics, United Kingdom, 2022 report, over 11 million people representing 18.6% of the total population, were aged 65 years or older in England and Wales. This comprised 527,900 individuals who were 90 years of age or older. In England and Wales, the average (median) age increased to 40 years in 2021, reflecting changes in the population's age distribution. Therefore, the high burden of the aging population in the country is estimated to propel the market growth over the forecast period.
UK Neurology Devices Industry Overview
The UK neurology devices market is slightly fragmented in nature due to the presence of many companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known. Some key market players are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Johnson and Johnson Services Inc., Medtronic PLC, MicroPort Scientific Corporation, Nihon Kohden Corporation, Penumbra Inc., Smith & Nephew, and Stryker Corporation among others.
UK Neurology Devices Market Leaders
-
B. Braun Melsungen AG
-
Boston Scientific
-
Stryker Corporation
-
Medtronic PLC
-
Abbott Laboratories
*Disclaimer: Major Players sorted in no particular order
UK Neurology Devices Market News
- March 2022: Sky Medical Technology Ltd, a United Kingdom-based company, received Food and Drug Administration 510(k) clearance for its W3 Geko device for increasing microcirculatory blood flow in lower limb soft tissue of patients with venous insufficiency or ischemia.
- February 2022: Medtronic PLC received approval from the Food and Drug Administration (FDA) for InterStim X. The most individualized system for delivering sacral neuromodulation (SNM) therapy is the InterStim system, which is the gold standard in advanced therapy alternatives.
UK Neurology Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increase in Incidence of Neurological Disorders
- 4.2.2 Rise in the Aging Population
-
4.3 Market Restraints
- 4.3.1 High Cost of Devices
- 4.3.2 Stringent Regulatory Validation and Guidelines for New Devices
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value- USD million)
-
5.1 By Type of Device
- 5.1.1 Cerebrospinal Fluid Management Devices
- 5.1.2 Interventional Neurology Devices
- 5.1.3 Neurosurgery Devices
- 5.1.4 Neurostimulation Devices
- 5.1.5 Other Types of Devices
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Abbott Laboratories
- 6.1.2 B. Braun Melsungen AG
- 6.1.3 Boston Scientific Corporation
- 6.1.4 Johnson and Johnson
- 6.1.5 Medtronic PLC
- 6.1.6 MicroPort Scientific Corporation
- 6.1.7 Nihon Kohden Corporation
- 6.1.8 Penumbra Inc.
- 6.1.9 Smith & Nephew
- 6.1.10 Stryker Corporation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityUK Neurology Devices Industry Segmentation
As per the scope of the report, neurological devices are medical devices that help to diagnose, prevent, and treat a variety of neurological disorders and conditions, such as Alzheimer's disease, Parkinson's disease, major depression, and traumatic brain injury. The growth of neurological devices is being driven through an emphasis on developing superior neuromodulation and neurostimulation techniques, leveraging minimally invasive procedures that benefit patients. The UK neurology devices market is segmented by type of device (cerebrospinal fluid management devices, interventional neurology devices, neurosurgery devices, neurostimulation devices, and other types of devices). The report offers the value (in USD million) for the above segments.
| By Type of Device | Cerebrospinal Fluid Management Devices |
| Interventional Neurology Devices | |
| Neurosurgery Devices | |
| Neurostimulation Devices | |
| Other Types of Devices |
UK Neurology Devices Market Research FAQs
What is the current United Kingdom Neurology Devices Market size?
The United Kingdom Neurology Devices Market is projected to register a CAGR of 7.5% during the forecast period (2024-2029)
Who are the key players in United Kingdom Neurology Devices Market?
B. Braun Melsungen AG, Boston Scientific, Stryker Corporation, Medtronic PLC and Abbott Laboratories are the major companies operating in the United Kingdom Neurology Devices Market.
What years does this United Kingdom Neurology Devices Market cover?
The report covers the United Kingdom Neurology Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the United Kingdom Neurology Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Bariatric Surgery in UK Industry Report
Statistics for the 2024 Bariatric Surgery in UK market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Bariatric Surgery in UK analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
